SCHEMBL20608017

SCHEMBL20608017

N#CN1CCC2(CNC(c3ccccc3)C2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
OTUD7B Q6GQQ9 12/20 0.39
USP30 Q70CQ3 2/20 0.32
DPP4 P27487 1/20 0.32
CTSC P53634 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24673970 0.70 OTUD7B (0.65) OTUD7B
SCHEMBL20721818 0.70 OTUD7B (0.65) OTUD7B
SCHEMBL3396699 0.65 PRCP (0.40)
SCHEMBL3423453 0.62 PRCP (0.38)
SCHEMBL18863654 0.62 PRCP (0.40)
SCHEMBL18863653 0.62 PRCP (0.40)
SCHEMBL3574526 0.62 KDM1A (0.44)
SCHEMBL13342746 0.61 GRIN2D (0.44) OTUD7B
SCHEMBL13368587 0.61 LMNA (0.41) OTUD7B
SCHEMBL24481844 0.61 PRCP (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4067355-A1 SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYME (DUB) INHIBITORS Mission Therapeutics Limited (GB) 2022-10-05 EP disclosed
EP-3423454-B1 SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS MISSION THERAPEUTICS LTD (GB) 2022-05-25 EP disclosed
CN-108602823-B Spiro-condensed pyrrolidine derivatives as Deubiquitinase (DUB) inhibitors 特殊治疗有限公司 2022-04-01 CN disclosed
EP-3423454-A1 SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS Mission Therapeutics Limited (GB) 2019-01-09 EP disclosed